Andere talen Anteris Technologies Ltd OTC Markets

Aandelen

AMEU.F

AU0000088841

Vertraagde tijd OTC Markets Andere beurzen 16:45:00 21-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
13,5 ^USD	+2,66%		-.--%	+2,27%

10/04	Anteris Technologies haalt AU$23 miljoen op voor DurAVR-studie	MT
13/03	Anteris meldt positieve resultaten van onderzoeken naar hartkleppen bij mensen	MT

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Anteris Technologies achieves breakthrough in triple valve replacement using DurAVRâ„¢	16/05
Anteris Technologies Completes Valve-in-Valve-in-Valve Procedure with DurAVR	15/05
Anteris Technologies Posts AU$10.6 Million Cash, AU$20.2 Million Net Cash Outflows for Quarter Ended March 31	18/04
Anteris Technologies Raises AU$23 Million for DurAVR Study	10/04
Anteris Declares Upbeat Results from Human Trials of Heart Valve	13/03
Anteris Technologies Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	28/02
Anteris talks market superiority of its biomimetic TAVR valve	31-10-23
Anteris Technologies Completes Enrollment for Heart Valve Device Study	17-10-23
Anteris Technologies Secures AU$1 Million Tax Rebate for 2022	13-10-23
Anteris Technologies Ltd(ASX:AVR) dropped from S&P Global BMI Index	18-09-23
Anteris Announces Participation at the Cantor Healthcare Conference on Sept 26th 2023	12-09-23
Anteris Technologies Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	25-08-23
Anteris Technologies Ltd - DurAVR Demonstrates Exceptional Results in Second Valve-in-Valve Case	15-08-23
DurAVR™ THV Demonstrates Exceptional Results in Second Valve-in-Valve Case	14-08-23
Anteris Technologies Ltd Announces DurAVR THV Demonstrates Exceptional Results in Second Valve-in-Valve Case	14-08-23
Anteris Technologies Ltd - Montefiore Health System Enrolls Patients in the US Early Feasibility Study	10-08-23
Anteris Technologies Commences American Depository Receipt Program	09-08-23
Anteris Technologies Commences US Early Feasibility Study	09-08-23
Montefiore Enrolls Patients for US Early Feasibility Study for Anteris Technologies' DurAVR THV	09-08-23
Anteris welcomes successful DurAVR valve-in-valve procedure	01-08-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Anteris Technologies Ltd OTC Markets

Aandelen

AMEU.F

AU0000088841

Andere talen

Filters